| 國立成功大學 |
2020-07 |
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry
|
Wu;Hsin-Yi;Pan;Yu-Yi;Kopylov;Arthur, T.;Zgoda;Victor;Ma;Mi-Chia;Wang;Ching-Hsun;Su;Wu-Chou;Lai;Wu-Wei;Cheng;Pin-Nan;Liao;Pao-Chi |
| 國立成功大學 |
2020-05-14 |
Silver-coated zero-valent iron nanoparticles enhance cancer therapy in mice through lysosome-dependent dual programed cell death pathways: triggering simultaneous apoptosis and autophagy only in cancerous cells
|
Yang;Li-Xing;Wu;Ya-Na;Wang;Pei-Wen;Huang;Kuang-Jing;Su;Wu-Chou;Shieh;Dar-Bin |
| 國立成功大學 |
2020-04-8 |
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
Yang;Szu-Chun;Lai;Wu-Wei;Hsu;Jason, C.;Su;Wu-Chou;Wang;Jung-Der |
| 國立成功大學 |
2019-11 |
Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up
|
Yang;Szu-Chun;Kuo;Chin-Wei;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou;Chang;Sheng-Mao;Wang;Jung-Der |
| 國立成功大學 |
2019-10 |
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
|
Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2019-09-2 |
Iron Release Profile of Silica-Modified Zero-Valent Iron NPs and Their Implication in Cancer Therapy
|
Yang;Li-Xing;Wu;Ya-Na;Wang;Pei-Wen;Su;Wu-Chou;Shieh;Dar-Bin |
| 國立成功大學 |
2019-08 |
Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC
|
Lin;Chia-Ying;Chang;Chao-Chun;Su;Po-Lan;Lin;Chien-Chung;Tseng;Yau-Lin;Su;Wu-Chou;Yen;Yi-Ting |
| 國立成功大學 |
2019-07-16 |
Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison
|
Chen;Yi-Lin;Lin;Chien-Chung;Yang;Shu-Ching;Chen;Wan-Li;Chen;Jian-Rong;Hou;Yi-Hsin;Lu;Cheng-Chan;Chow;Nan-Haw;Su;Wu-Chou;Ho;Chung-Liang |
| 國立成功大學 |
2019-03 |
Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy-based F-18-FDG PET/CT in stage Ill non-small cell lung cancer
|
Chen;Helen, Helen H. W.;Su;Wu-Chou;Guo;How-Ran;Lee;Bi-Fang;Chiu;Nan-Tsing |
| 國立成功大學 |
2019-01 |
Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis
|
Lin;Chung-Ying;Hwang;Jing-Shiang;Wang;Wen-Chung;Lai;Wu-Wei;Su;Wu-Chou;Wu;Tzu-Yi;Yao;Grace;Wang;Jung-Der |
| 國立成功大學 |
2018-11 |
Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma
|
Wei;Yu-Feng;Chu;Chang-Yao;Chang;Chao-Chun;Lin;Sheng-Hsiang;Su;Wu-Chou;Tseng;Yau-Lin;Lin;Chien-Chung;Yen;Yi-Ting |
| 國立成功大學 |
2018-11 |
Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment
|
Wei;Fang;Strom;Charles, M.;Cheng;Jordan;Lin;-Chung, Chien;Hsu;Ching-Yun;Hoo;Soo, Guy W.;Chia;David;Kim;Yong;Li;Feng;Elashoff;David;Grognan;Tristan;Tu;Michael;Liao;Wei;Xian;Rena;Grody;Wayne, Wayne W.;Su;Wu-Chou;Wong;David, T. W. |
| 國立成功大學 |
2018-10-1 |
Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype
|
Tzeng;Hong-Tai;Su;Ching-Chin;Chang;Chih-Peng;Lai;Wu-Wei;Su;Wu-Chou;Wang;Yi-Ching |
| 國立成功大學 |
2018-09-25 |
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
|
Su;Po-Lan;Wu;Yi-Lin;Chang;Wei-Yuan;Ho;Chung-Liang;Tseng;Yau-Lin;Lai;Wu-Wei;Su;Wu-Chou;Lin;Chien-Chung;Yang;Szu-Chun |
| 國立成功大學 |
2018-09-12 |
Autophagy regulates vinorelbine sensitivity due to continued Keap1-mediated ROS generation in lung adenocarcinoma cells
|
Wu;Yan-Wei;Lin;Chiou-Feng;Lin;Yee-Shin;Su;Wu-Chou;Chiu;Wei-Hsin |
| 國立成功大學 |
2018-08-29 |
Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness
|
Cho;Shu-Huei;Kuo;I-Ying;Lu;Frank, Pei-Jung;Tzeng;Hong-Tai;Lai;Wu-Wei;Su;Wu-Chou;Wang;Yi-Ching |
| 國立成功大學 |
2018-06 |
Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy
|
Yen;Chih-Chieh;Su;Hui-Chen;Chu;Chang-Yao;Lai;Shi-Jie;Yan;Jing-Jou;Su;Wen-Pin;Su;Wu-Chou |
| 國立成功大學 |
2018-02-5 |
Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer
|
Yang;Szu-Chun;Lin;Chien-Chung;Lai;Wu-Wei;Chang;Sheng-Mao;Hwang;Jing-Shiang;Su;Wu-Chou;Wang;Jung-Der |
| 國立成功大學 |
2018-02-15 |
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
|
Chang;Wei-Yuan;Wu;Yi-Lin;Su;Po-Lan;Yang;Szu-Chun;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2017-11 |
Bimetallic nanoplasmonic gap-mode SERS substrate for lung normal and cancer-derived exosomes detection
|
Sivashanmugan;Kundan;Huang;Wei-Lun;Lin;Chen-Hsueh;Liao;Jiunn-Der;Lin;Chien-Chung;Su;Wu-Chou;Wen;Ten-Chin |
| 國立成功大學 |
2017-10-15 |
The c.1085A > G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages
|
Yeh;Yu-Min;Hsu;Shan-Ju;Lin;Peng-Chan;Hsu;Keng-Fu;Wu;Pei-Ying;Su;Wu-Chou;Chang;Jang-Yang;Shen;Meng-Ru |
| 國立成功大學 |
2017-03-14 |
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
|
Huang;Wei-Lun;Chen;Yi-Lin;Yang;Szu-Chun;Ho;Chung-Liang;Wei;Fang;Wong;David, T.;Su;Wu-Chou;Lin;Chien-Chung |
